DENTSPLY SIRONA Inc. provided earnings guidance for the year ended December 31, 2023. For the period, the Company anticipates its estimated net sales for the year ended December 31, 2023 will be at or above the high end of its previously provided outlook range of $3.90 billion to $3.94 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.57 USD | +0.72% | +0.23% | -14.11% |
Apr. 03 | DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) added to S&P 1000 | CI |
Apr. 03 | DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) added to S&P 400 Health Care | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.11% | 6.35B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- XRAY Stock
- News DENTSPLY SIRONA Inc.
- Dentsply Sirona Inc. Provides Earnings Guidance for the Year Ended December 31, 2023